ScholarWorks@SUNGKYUNKWAN UNIVERSITY: KIM, JUNG HAN

Detailed Information

KIM, JUNG HAN (김정한)

Medicine (Medicine)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Breast neoplasms:8||thyroid cancer:8||Breast cancer:6||papillary thyroid carcinoma:6||MMP9:6||Papillary thyroid carcinoma:5||metastasis:5||breast cancer:5||Breast:5||Prognosis:5||Melanoma:4||Thyroid cancer:4||sentinel lymph node biopsy:4||Ultrasonography:4||thyroidectomy:3||Lymph nodes:3||BRAF mutation:3||pheochromocytoma:3||total thyroidectomy:3||Endoscopic thyroidectomy:3||prognosis:3||survival:3||thyroid neoplasm:3||BRAF:3||Silibinin:3||central neck dissection:3||central lymph node metastasis:3||calcitonin:3||Treatment:2||thyroid:2||Immunohistochemistry:2||fineneedle aspiration:2||Hereditary:2||KIT mutation:2||Acral melanoma:2||mortality:2||CT:2||adrenal gland:2||cN1a:2||Pediatric papillary thyroid carcinoma:2||ultrasonography:2||Metanephrine:2||Follicular thyroid carcinoma:2||Carcinoma:2||endoscopic thyroidectomy:2||Diagnosis:2||Mortality:2||p53:2||BRCA2 gene mutation:2||Lymph node:2||TNM staging:2||Lymphoscintigraphy:2||Berberine:2||remission:2||Republic of Korea:2||lymph nodes:2||Silybum marianum:2||gastric cancer:2||silibinin:2||Survival:2||Bilateral axillobreast approach:2||medullary thyroid cancer:2||Robotic thyroidectomy:2||Iodine radioisotopes:1||JAKs:1||KIT amplificati:1||KIT amplification:1||KIT gene:1||Ki67 proliferation index:1||Kidney transplant:1||LUS:1||Laparoscopy:1||Largest metastatic lymph node size:1||Lateral neck metastasis:1||Lobular carcinoma:1||Lower extremity:1||Lymph no:1||Lymph node ratio:1||Lymphatic metastasis:1||Lysosome:1||MCF7 human breast cancer cells:1||MMP1:1||Magnetic resonance imaging:1||Male breast cancer:1||Malignant melanoma:1||Mastectomy:1||Matrix metalloproteinase9 (MMP9):1||Metastasis:1||Minimal N1b:1||Molecular subtype:1||Mucosal melanoma:1||Mutation:1||Mutation rate:1||Myelolipoma:1||NIFTP:1||Neoadjuvant therapy:1||Neoplasm invasiveness:1||Neoplasm metastasis:1||Neoplasm staging:1||Nilotinib:1||Nomograms:1||PDL1:1||PD1:1||PDL1:1||PKCalpha:1||Papillary:1||Papillary thyroid microcarcinoma:1||Papillomavirus, human:1||Parathyroid:1||Pheochoromocytoma:1||Pheochromocytoma:1||Popliteal:1||Port insertion site recurrence:1||Predictive marker:1||Prevention:1||Prognostic factor:1||Prognostic markers:1||Proteasome:1||RAS mutations:1||Rabbit model:1||Radiotherapy:1||Radiotherapy Recurren:1||Rare benign adrenal tumor:1||Ratio:1||Recurrence:1||Res:1||Risk factors for contralateral central neck metastasis in patients with unilateral N1b:1||Robotic thyroid surgery:1||SKBR3 cells:1||SPECT:1||SPECT/CT:1||STAT3:1||Salpingoovariectomy:1||Schwannoma:1||Screendetected:1||Secondary lymphedema:1||Segmental:1||Sentine:1||Sentinel lymph node:1||Sentinel lymph node biopsy:1||Sestamibi:1||Surgical complications of bilateral central neck dissection:1||Surgical strategy for cN1a PTC patients:1||Surgical treatment for PTMC patients with unilateral cN1a:1||TERT:1||TERT promoter:1||TGFα:1||TNFalpha:1||TPA:1||TSH suppression:1||Tattooing:1||Technetium 99m Sestamibi:1||Telomerase reverse transcriptase:1||Thyroid hemiagenesis:1||Thyroid neoplasm:1||Thyroid neoplasms:1||Thyroidectomy:1||Urine:1||Vascular endothelial growth factor (VEGF):1||acral melanoma:1||active surveillance:1||adenocarcinoma:1||adrenal mass:1||age:1||anaplastic carcinoma:1||angioimmunoblastic Tcell lymphoma:1||apoptosis:1||b:1||berberine:1||bilaterality:1||biomarker:1||breast:1||breast carcinoma:1||breast conserving surgery:1||calcitriol:1||carcinoma:1||chemotherapy:1||childhood:1||cholecalciferol:1||chronic lymphocytic thyroiditis:1||chyle leakage:1||clinical decisionmaking:1||clinical features:1||clinical manifestation:1||clinical relevance:1||computed tomography (CT):1||conservative management:1||contrast enhancement:1||core needle biopsy:1||critical presentations:1||cutoff value:1||cytokine:1||dacarbazine:1||delayed recovery:1||dendritic cell:1||diagnosis:1||dietary modification:1||differentiated thyroid carcinoma:1||disease:1||disease free survival:1||drugrelated side effects and adverse reactions:1||dynamic risk stratification:1||early stage:1||endocrinetumors:1||endoscopic total thyroidectomy:1||epidermal growth factor receptor:1||excision margin:1||extrathyroidal extension:1||false negative rates:1||falsenegative rate:1||family history:1||follicular:1||gel pad:1||hypertension:1||immunotherapy:1||interleukin10:1||intermediaterisk:1||intestinal:1||isosulfan blue:1||laryngeal ultrasound:1||lateral lymph node metastasis:1||lateral neck node:1||level V dissection:1||level V metastasis:1||local recurrence:1||lung:1||lymph node dissection:1||lymph node excision:1||marginal zone B cell lymphoma:1||marginal zone Bcell lymphoma:1||marginal zone Bcell lymphoma of MALT type:1||medullary:1||medullary thyroid carcinoma:1||melanoma:1||metanephrine:1||methylation:1||methylene blue:1||modified radical neck dissection:1||molecular diagnostic technique:1||multifocality:1||neoadjuvant chemotherapy:1||neoplasm:1||neoplasm metastasis:1||neuronal apoptosis inhibitory protein (NAIP):1||nomogram:1||noncutaneous melanoma:1||nongastric:1||oral calcium:1||p21:1||pain management:1||papillary carcinoma:1||papillary lesion:1||papillary thyroid cancer:1||papillary thyroid microcarcinoma:1||paraganglioma:1||pediatrics:1||peripheral calcifications:1||phenylethanolamine Nmethyltransferase:1||pheochromocytoma/paraganglioma:1||phorbol ester:1||phosphorylated signal transducer and activator of transcription 3:1||prognostic factor:1||prognostic index:1||prospective study:1||radioactive iodine ablation:1||radioactive iodine therapy:1||radioisotope:1||realtime quantitative polymerase chain reaction:1||recurrence:1||recurrence pattern:1||relapse:1||renal cell carcinoma:1||ropivacaine:1||secondary:1||sentinel lymph node:1||serum thyroglobulin:1||structural disease:1||surgical excision:1||surgical flap:1||suspicious palpable lymph node biopsy:1||thoracic duct ligation:1||thyroid carcinoma:1||thyroid surgery:1||thyrotrophin:1||thyrotropin receptor antibody:1||thyrotropinbinding inhibitory immunoglobulins:1||treatment:1||treatment outcomes:1||trocar site recurrence:1||tumor growth:1||tumor lysate:1||tumor size:1||vacuum biopsy:1||vascular endothelial growth factor receptor 1:1||vascular invasion:1||vocal cord:1||volumetry:1||washout thyroglobulin:1||young:1||골수지방종:1||부신 희귀 양성종양:1||부신낭종:1||신경수초종:1||(V600E):1||신경절신경종:1||12Otetradecanoyl phorbol13acetate (TPA):1||AP1:1||Absorbable implants:1||Adenocarcinoma:1||Adjuvant chemotherapy:1||Adrenal cyst:1||Adrenocortical adenoma:1||Aged:1||Axillary:1||BABA endoscopic thyroidectomy:1||BRAFprevalent population:1||BRCA2:1||Bilateral axillary approach:1||Bilateral mastectomy:1||Bmi1:1||Breast cancer metastasis:1||Breast conserving surgery:1||Breast neoplasm:1||Breast reconstruction:1||CD44:1||Cdc2:1||Cell cycle regulator:1||Cell invasion:1||Central neck dissection:1||Chemotherapy:1||Chip:1||CollaStat:1||Combined mo:1||Contralateral central neck metastasis and recurrence:1||Cushing syndrome:1||Cyclin B1:1||Diffuse large Bcell lymphoma:1||EGF:1||EGFR:1||ERK:1||ErbB2:1||Excisio:1||Extensive N1b:1||Extrathyroidal extensions in children with differentiated thyroid cancers:1||FloSeal:1||Follicular neoplasm:1||Frozen section analysis:1||Gamma cameras:1||Gamma probe:1||Ganglioneuroma:1||Granulomatous mastitis:1||Graves&apos:1||HER2/neu discordance:1||HLTF:1||HPV DNA chip typing:1||Hemostasis:1||Hemostatic agent:1||Hurthle cell neoplasm:1||Hyperaldosteronism:1||Hyperparathyroid:1||I131 scintigraphy:1||Ileum:1||Immune checkpoint inhibitor:1||Immunogenicity:1||Interventional ultrasonography:1||Intracystic papillary carcinoma:1||Intramammary lymph node:1||

STATISTICS: Total View :5,221,121; Today View :0

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE